Pipeline· August 11, 2026 · 14 min read
Ivonescimab: the PD-1/VEGF Bispecific Ahead of Nov 2026 FDA Action
By Ran Chen#FDA Approval#Oncology#Bispecific Antibody
Topic
Bispecific Antibody
Bispecific antibody launches, administration setting, oncology access, evidence, and safety management.
Pipeline· July 23, 2026 · 21 min read
Bispecific Antibody & T-Cell Engager Clinical Trials by the Numbers (2026)
Pricing & Access· June 10, 2026 · 10 min read